Thursday, May 02, 2019

Synthetic biology used to target cancer cells while sparing healthy tissue, study reports

Synthetic proteins engineered to recognize overly active biological pathways can kill cancer cells while sparing their healthy peers, according to a study by researchers at the Stanford University School of Medicine.

* This article was originally published here